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Introduction
The hypothalamic paraventricular nucleus (PVN) is widely known to be a crucial autonomic control centre that plays essential roles in energy homeostasis, fluid balance and cardiovascular regulation, through neuroendocrine and autonomic functions (Swanson & Sawchenko, 1983) . Within the PVN exist three subpopulations of neurons, the magnocellular (MNC) neurosecretory, parvocellular pre-autonomic (PA) and parvocellular neuroendocrine (NE) neurons (Swanson & Sawchenko, 1983) . The MNC neurons project to the posterior pituitary, where they release vasopressin and oxytocin (OT) into the general circulation. In addition to their neurohypophysial projection, axons of OT-secreting MNC neurons send collaterals to several forebrain regions, including the central amygdala and nucleus accumbens (Knobloch et al. 2012) . The PA neurons project to autonomic centres in the medulla and spinal cord, including the nucleus tractus solitarii (NTS; Kannan & Yamashita, 1985) , to influence autonomic control. Finally, NE neurons project to the median eminence, where they secrete hypophysiotrophic hormones, including corticotrophin-releasing hormone (CRH) and thyrotrophin-releasing hormone.
The PVN receives afferent projections from additional hypothalamic regions, including the lateral hypothalamus and arcuate nucleus (Swanson & Sawchenko, 1983) . Inputs are also received from extrahypothalamic sites, including the subfornical organ (Swanson & Sawchenko, 1983) , one of the sensory circumventricular organs. The PVN integrates information provided by a vast number of signalling molecules, many of which are circulating hormones that also act as neuropeptides within the CNS (Table 1) and could be thought of collectively as the alphabet for communication in this crucial autonomic control centre. In this review, we highlight four cardiovascular/metabolic peptides that signal within the PVN and present preliminary data indicating that the genes for some of these molecules and their receptors are differentially expressed in males and females.
Angiotensin II
Angiotensin II (Ang II), a crucial component of the renin-angiotensin system (RAS) and potent vasoconstrictor, is perhaps the most studied peptide hormone involved in cardiovascular regulation. As it is unlikely that Ang II can freely cross the blood-brain barrier, circulating Ang II must signal in the brain through the sensory circumventricular organs. Indeed, a subfornical organ-PVN pathway has been well characterized, with neuronal projections from the subfornical organ to the PVN using Ang II as a neurotransmitter . The Ang II type 1 (AT 1 ) receptor is expressed predominantly in NE neurons, specifically in those 
Note that references supporting roles for each of these peptides in the paraventricular nucleus can be found through PubMed search for paraventricular nucleus and the relevant peptide. They have not been included here given Journal limitations on the number of references.
that express CRH and thyrotrophin-releasing hormone (de Kloet et al. 2017) . Unsurprisingly, optogenetic stimulation of these neurons results in activation of their respective axes, the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid (HPT) axes (de Kloet et al. 2017) . Systemic administration of the AT 1 blocker, losartan, which can cross the blood-brain barrier, abrogates the Ang II-induced hypertensive effects of activation of the subfornical organ-PVN pathway .
Angiotensin II has excitatory electrophysiological effects on PVN neurons from all three subpopulations ( Fig. 1A and B) . In NE neurons, Ang II directly depolarizes these cells by specifically modulating both a non-selective cationic current and a K + current (Latchford & Ferguson, 2005) . Angiotensin II has indirect depolarizing effects on MNC neurons mediated via glutamate interneurons (Latchford & Ferguson, 2004) and direct excitatory effects on PA neurons that project to the rostral ventrolateral medulla (Cato & Toney, 2005) . With these heterogeneous excitatory effects of Ang II, it is not surprising that this peptide influences more than cardiovascular function. Angiotensin II, along with the other components of the RAS, has also been implicated in energy homeostasis.
Similar to its effects on blood pressure, losartan has also been shown to attenuate body weight gain in obese and diet-resistant rats fed a high-fat diet (Smith et al. 2014) . Paraventricular nucleus AT 1a knockout mice fed a high-fat diet have increased adiposity attributable to both increased energy consumption and decreased energy expenditure (de Kloet et al. 2013) . These mice also exhibit decreased blood pressure and hypothalamic mRNA expression of CRH and OT (de Kloet et al. 2013) . Electrophysiologically, this AT 1a deletion eliminates the responsiveness of PVN parvocellular neurons to bath-applied Ang II (de Kloet et al. 2013) . These results suggest that Ang II signals in the PVN via AT 1a receptors in parvocellular neurons to regulate energy balance and to mediate part of its effect on blood pressure.
Preliminary transcriptome data from our laboratory have revealed sex-specific differences between some of the genes for components of the RAS. The gene for the precursor of Ang II, Agt, displays the greatest difference in expression, being ß1.3-fold higher in males versus females (Fig. 1C) . Although the Ang II receptor, AT 1 , is not differentially expressed (Fig. 1C) , the increased expression of AGT may lead to increased levels of Ang II and a subsequent increase in blood pressure. As the RAS is also implicated in energy homeostasis, these sex-specific differences might also contribute to their effects on obesity.
Orexin
Orexins/hypocretins (OX-A and OX-B or hypocretin 1 and hypocretin 2, respectively), as their name suggest, are potent orexigenic peptides derived from a common precursor and are almost exclusively expressed in the lateral hypothalamic area (Sakurai et al. 1998) . There are two OX receptors, OX 1 R and OX 2 R, both of which bind each OX isoform (Sakurai et al. 1998) . OX-A has a higher affinity for the OX 1 R than OX-B, whereas both isoforms have equal affinity for the OX 2 R (Sakurai et al. 1998) . Lateral hypothalamic neurons, including those that are OX immunoreactive, project to the PVN (Peyron et al. Angiotensin II application is represented by the horizontal grey bars. B, mean ± SEM change in resting membrane potential (RMP) elicited by bath application of 10 −8 , 10 −7 , 10 −6 and 10 −5 M Ang II. Data were fitted to a sigmoid concentration-response function, and the corresponding curve of best fit was overlaid. C, preliminary transcriptome data comparing the expression level of angiotensin-related genes in male versus female rats. Abbreviations: Ace2, angiotensin-converting enzyme 2; Agt, angiotensinogen; and Agtr1a, angiotensin II type 1a receptor.
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1998). Additionally, OX receptors are expressed in PVN neurons (Backberg et al. 2002) , thus implicating this nucleus in OX-mediated signalling. Indeed, researchers in our laboratory have demonstrated indirect and direct depolarizing effects of OX on MNC and parvocellular PVN neurons, respectively ( Fig. 2A and B ; Follwell & Ferguson, 2002) . In addition to their effects on food intake, both OX-A and OX-B have hypertensive effects when administered centrally (Shirasaka et al. 1999) . In male obese Zucker rats, microinjection of OX-A into the PVN increases blood pressure and renal sympathetic nerve activity, presumably through upregulation of OX 1 R in PVN PA neurons projecting to the spinal cord (Zhou et al. 2015) . These results suggest that OX signalling in the PVN contributes to obesity-related hypertension. In addition, immobilization stress-induced ACTH stimulation is blocked by pretreatment with an OX 1 R antagonist, which also abolishes the OX-A-induced increase in blood pressure (Samson et al. 2007 ). These findings suggest that OX-A acts in the PVN to activate the hypothalamic-pituitary-adrenal axis.
Based on our transcriptome data, only one of the orexin receptors, OX 2 R, exhibits a sex-specific difference, with greater expression in females than males, whereas the expression of OX 1 R is similar in both sexes (Fig. 2C) . These data are in agreement with a study that looked at nicotine exposure in piglets and observed an increase in OX 2 R in the PVN of female animals after nicotine treatment (Hunt et al. 2013 ). These differences may have important implications for the effects of OX in each sex when we consider that the OX isoforms have varying affinities for each OX receptor. 
. Orexin (OX) influences the excitability of neurons in the PVN
A, representative current-clamp recordings from three separate PVN neurons showing that bath application of OX-A (500 nM, top; 100 nM, middle) or OX-B (100 nM, bottom) results in depolarization of the membrane potential. The time of OX application is indicated by the horizontal red bars. B, mean ± SEM change in membrane potential elicited by bath application of 1, 10, 50, 100 and 500 nM OX-A. Data were fitted to a sigmoid concentration-response function, and the corresponding curve of best fit was overlaid. C, preliminary transcriptomic data comparing the expression level of the orexin receptor genes in male versus female rats. Abbreviations: ORX1R, orexin receptor type 1; and ORX2R, orexin receptor type 2.
and AdipoR2 (Yamauchi et al. 2003) , both of which are expressed in PVN neurons (Hoyda et al. 2007) . AdipoR knockout mice exhibit differential effects on energy metabolism. AdipoR1 −/− mice have increased adiposity along with decreased glucose tolerance and energy expenditure, whereas AdipoR2 −/− mice are resistant to high-fat diet-induced obesity and have improved glucose tolerance (Bjursell et al. 2007) . Likewise, ADP has differential electrophysiological effects on MNC neurons that appear to be correlated with AdipoR expression, suggesting that neurons expressing both AdipoRs hyperpolarize, whereas those that express only AdipoR2 depolarize ( Fig. 3A ; Hoyda et al. 2007 ). In addition to receptor profiles, researchers in our laboratory have also characterized ADP responses to the molecular phenotype of PVN neurons; MNC neurons that express OT hyperpolarize in response to ADP (Hoyda et al. 2007 ). Intriguingly, this peptide depolarizes PA OT neurons (Hoyda et al. 2009a) , indicating that ADP has opposite effects on functionally distinct OT-expressing PVN neurons.
We have shown a direct depolarizing effect of ADP on NE CRH neurons in the PVN (Fig. 3B) , leading to subsequent release of ACTH (Hoyda et al. 2009a) . Similar direct depolarizing effects of ADP were found to occur in NTS neurons that express neuropeptide Y, further implicating ADP in feeding behaviour (Hoyda et al. 2009b) . Additionally, direct injection of ADP into the NTS decreases blood pressure (Hoyda et al. 2009b) , and nanoinjection of neuropeptide Y into the PVN induces a similar pressor response (Cassaglia et al. 2014) . As the parvocellular region of the PVN receives afferent projections from the NTS (Kannan & Yamashita, 1985) , these results provide an indirect mechanism of ADP-mediated CRH secretion via the NTS. The reciprocal connections between the PVN and the NTS, and the actions of ADP on both nuclei, suggest a dual effect of this peptide on both feeding behaviour and cardiovascular function.
Although ADP itself does not display a sex-specific difference in expression, one of its receptors does. The gene for AdipoR1 has increased expression in females compared with males (Fig. 3C) . As ADP signalling depends on the AdipoR expression profile, this differential gene expression might cause differences in the effects of ADP in males versus females, at least at the cellular level.
Nesfatin-1
Nesfatin-1 is an anorexigenic peptide derived from the precursor, nucleobindin2 (NUCB2; Oh et al. 2006) . NUCB2 is expressed in multiple hypothalamic nuclei, including the lateral hypothalamic area, the arcuate nucleus, the supraoptic nucleus and the PVN S. P. Loewen and others (Oh et al. 2006) . During starvation, the concentration of nesfatin-1 is reduced in the PVN, while remaining unchanged in the other hypothalamic nuclei (Oh et al. 2006) . Paraventricular nucleus-specific NUCB2 mRNA knockdown in mice increases food intake, leading to subsequent obesity (Nakata et al. 2016) . Additionally, central pretreatment with an OT receptor antagonist blocks the inhibitory effect of nesfatin-1 on food intake (Yosten & Samson, 2010) , implicating OT in nesfatin-1-mediated feeding behaviour. Clearly, the PVN is involved in mediating the feeding effects of nesfatin-1. In addition to its role in food intake, nesfatin-1 has also been implicated in cardiovascular function, as central administration has been shown to increase blood pressure in rats (Yosten & Samson, 2009 ). This nesfatin-1-induced pressor effect occurs through the central melanocortin pathway (Yosten & Samson, 2009) , the same pathway used by this peptide for its effect on food intake (Oh et al. 2006) . Additionally, pretreatment with an OT receptor antagonist abrogates both the anorexigenic and the hypertensive effects of nesfatin-1 (Yosten & Samson, 2010) , again implicating OT, and thus the PVN, in mediating these nesfatin-1 effects. Nesfatin-1 has non-specific electrophysiological effects in the PVN, causing both depolarizations and hyperpolarizations in PVN neurons from all three subpopulations (Price et al. 2008) . Single-cell RT-PCR experiments revealed that these heterogeneous effects are not dependent on the molecular phenotype of these neurons, because both effects occur in PVN neurons that express OT, vasopressin, CRH or thyrotrophin-releasing hormone (Price et al. 2008) . Additional studies are required to relate the electrophysiological effects of nesfatin-1 in the PVN to a specific physiological action of the peptide; however, it is clear that this nucleus is involved in regulating the cardiovascular and metabolic effects of nesfatin-1. Although the receptor for nesfatin-1 remains elusive, transcriptome data on the precursor gene for nesfatin-1, Nucb2, show a similar expression in the PVN of both females and males.
Conclusion
Many signalling molecules that have traditionally been thought to influence only one major system in fact influence multiple systems. These effects, unsurprisingly, are often mediated at least in part by the PVN. We have highlighted four hormones that signal through the PVN and influence both cardiovascular and metabolic function. To study the electrophysiological effects of these hormones within the brain, many studies, including the numerous ones from our laboratory, often obtain data exclusively from male animals, in order to avoid the influence of the female oestrous cycle. However, the preliminary data presented in this review suggest sex-specific differences in gene expression that should be taken into consideration when performing experiments relating to these hormones or their receptors, especially if they involve both male and female animals. Future research should aim at elucidating potential mechanisms underlying these differences and determine whether these differences result in observable effects at the physiological level.
